Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09AX Other drugs for disorders of the musculo-skeletal system
M09AX11 Palovarotene
D09365 Palovarotene (JAN/USAN/INN) <US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Palovarotene
D09365 Palovarotene (JAN/USAN/INN)
Drug groups [BR:br08330]
Vitamin and mineral
DG01604 Retinol derivative
D09365 Palovarotene
Metabolizing enzyme substrate
DG02918 CYP2C8 substrate
D09365 Palovarotene
DG01639 CYP2C19 substrate
D09365 Palovarotene
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D09365 Palovarotene
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Retinoic acid receptor (RAR)
NR1B3 (RARG)
D09365 Palovarotene (JAN/USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09365
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09365
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09365